NewAmsterdam Cash from 2010 to 2026

NAMSW Stock

20.31 1.10 5.14%

NewAmsterdam Pharma Cash yearly trend continues to be fairly stable with very little volatility. Cash is likely to outpace its year average in 2026. Cash is the total amount of money in the form of currency that NewAmsterdam Pharma has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals

Cash

First Reported

2020-03-31

Previous Quarter

563.9 M

Current Value

538.4 M

Quarterly Volatility

275.6 M

Covid

Interest Hikes

Check NewAmsterdam Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NewAmsterdam Pharma's main balance sheet or income statement drivers, such as Net Interest Income of 20.4 M, Interest Income of 20.4 M or Depreciation And Amortization of 136.4 K, as well as many indicators such as Price To Sales Ratio of 32.1, Dividend Yield of 0.0 or PTB Ratio of 1.82. NewAmsterdam financial statements analysis is a perfect complement when working with NewAmsterdam Pharma Valuation or Volatility modules.

Build AI portfolio with NewAmsterdam Stock

Check out the analysis of NewAmsterdam Pharma Correlation against competitors.

For more information on how to buy NewAmsterdam Stock please use our How to Invest in NewAmsterdam Pharma guide.

The evolution of Cash for NewAmsterdam Pharma provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how NewAmsterdam Pharma compares to historical norms and industry peers.

Latest NewAmsterdam Pharma's Cash Growth Pattern

Below is the plot of the Cash of NewAmsterdam Pharma over the last few years. Cash refers to the most liquid asset of NewAmsterdam Pharma, which is listed under current asset account on NewAmsterdam Pharma balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from NewAmsterdam Pharma customers. The amounts must be unrestricted with restricted cash listed in a different NewAmsterdam Pharma account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. NewAmsterdam Pharma's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NewAmsterdam Pharma's overall financial position and show how it may be relating to other accounts over time.

Cash

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Cash

Timeline

NewAmsterdam Cash Regression Statistics

	Arithmetic Mean	204,394,177
	Geometric Mean	10,379,121
	Coefficient Of Variation	167.70
	Mean Deviation	279,686,381
	Median	1,365,094
	Standard Deviation	342,763,073
	Sample Variance	117486.5T
	Range	930.5M
	R-Value	0.79
	Mean Square Error	46181.6T
	R-Squared	0.63
	Significance	0.0001
	Slope	53,939,412
	Total Sum of Squares	1879784.4T

NewAmsterdam Cash History

	2026	931.9 M
	2025	887.5 M
	2024	771.7 M
	2023	340.4 M
	2022	467.7 M
	2021	60.4 M

Other Fundumenentals of NewAmsterdam Pharma

	Cash And Short Term Investments
	Change In Cash
	Free Cash Flow
	Begin Period Cash Flow

NewAmsterdam Pharma Cash component correlations

	Change In Cash	Free Cash Flow	Begin Period Cash Flow	End Period Cash Flow	Free Cash Flow Yield	Free Cash Flow Per Share	Cash Per Share	Ev To Free Cash Flow	Cash Ratio	Cash Conversion Cycle	Price Cash Flow Ratio	Cash Flow To Debt Ratio
Change In Cash		-0.58	0.58	0.91	0.14	-0.41	0.71	0.4	0.48	0.76	0.52	0.18
Free Cash Flow	-0.58		-0.97	-0.85	0.54	0.89	-0.27	-0.83	-0.02	-0.79	-0.27	0.59
Begin Period Cash Flow	0.58	-0.97		0.87	-0.46	-0.81	0.37	0.79	0.16	0.67	0.39	-0.68
End Period Cash Flow	0.91	-0.85	0.87		-0.15	-0.67	0.62	0.65	0.38	0.81	0.52	-0.24
Free Cash Flow Yield	0.14	0.54	-0.46	-0.15		0.81	0.28	-0.82	0.48	-0.15	-0.02	0.61
Free Cash Flow Per Share	-0.41	0.89	-0.81	-0.67	0.81		0.0	-0.91	0.3	-0.63	-0.11	0.51
Cash Per Share	0.71	-0.27	0.37	0.62	0.28	0.0		0.27	0.94	0.34	0.92	0.0
Ev To Free Cash Flow	0.4	-0.83	0.79	0.65	-0.82	-0.91	0.27		0.0	0.52	0.46	-0.59
Cash Ratio	0.48	-0.02	0.16	0.38	0.48	0.3	0.94	0.0		0.1	0.85	0.03
Cash Conversion Cycle	0.76	-0.79	0.67	0.81	-0.15	-0.63	0.34	0.52	0.1		0.15	-0.06
Price Cash Flow Ratio	0.52	-0.27	0.39	0.52	-0.02	-0.11	0.92	0.46	0.85	0.15		-0.2
Cash Flow To Debt Ratio	0.18	0.59	-0.68	-0.24	0.61	0.51	0.0	-0.59	0.03	-0.06	-0.2

Click cells to compare fundamentals

About NewAmsterdam Pharma Financial Statements

NewAmsterdam Pharma investors use historical fundamental indicators, such as NewAmsterdam Pharma's Cash, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NewAmsterdam Pharma. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Cash	887.5 M	931.9 M
Cash And Short Term Investments	959.3 M	1 B
Change In Cash	496 M	520.8 M
Free Cash Flow	-143.3 M	-136.1 M
Begin Period Cash Flow	391.5 M	411.1 M
Total Cashflows From Investing Activities	-56.6 M	-53.7 M
Other Cashflows From Financing Activities	16.1 M	16.9 M
Other Non Cash Items	94.3 M	99 M
Total Cash From Operating Activities	-142.7 M	-135.6 M
Total Cash From Financing Activities	758.4 M	796.4 M
End Period Cash Flow	887.5 M	931.9 M
Other Cashflows From Investing Activities	-27.6 K	-29 K
Free Cash Flow Yield	(0.08)	(0.08)
Operating Cash Flow Per Share	(1.93)	(2.03)
Free Cash Flow Per Share	(1.94)	(2.04)
Cash Per Share	7.96	6.58
EV To Operating Cash Flow	(9.39)	(9.86)
EV To Free Cash Flow	(9.35)	(9.81)
Price To Operating Cash Flows Ratio	(13.76)	(13.08)
Price To Free Cash Flows Ratio	(13.71)	(13.02)
Cash Ratio	6.50	6.10
Cash Conversion Cycle	153.60	87.76
Operating Cash Flow Sales Ratio	(4.00)	(4.20)
Free Cash Flow Operating Cash Flow Ratio	0.90	0.80
Cash Flow Coverage Ratios	(407.03)	(427.38)
Price Cash Flow Ratio	(13.76)	(13.08)
Cash Flow To Debt Ratio	(407.03)	(427.38)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

Additional Tools for NewAmsterdam Stock Analysis

When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

NewAmsterdam Cash from 2010 to 2026

Latest NewAmsterdam Pharma's Cash Growth Pattern

NewAmsterdam Cash Regression Statistics

NewAmsterdam Cash History

Other Fundumenentals of NewAmsterdam Pharma

NewAmsterdam Pharma Cash component correlations

About NewAmsterdam Pharma Financial Statements

Also Currently Popular

Additional Tools for NewAmsterdam Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY